General Information

Medical tourism is a practice of providing scheduled medical services outside a patient’s region of residence, combining travelling abroad with obtaining high quality medical care. Medical tourism does not necessarily involve obtaining medical services in another country; it can be classified as domestic, outbound and inbound. Domestic medical tourism refers to the citizens of one country travelling between its regions to obtain medical services. Outbound medical tourism is considered to be the import of medical services when a patient goes abroad to satisfy his medical needs. Inbound medical tourism is the export of medical services, that is attracting foreign patients to offer them medical assistance.

In his Address to the Federal Assembly of the Russian Federation on March 1, 2018, Russian President Vladimir Putin emphasized the need to develop healthcare and export services in medicine and tourism. In order to fulfill the President's instructions, the National Medical Research Center for Endocrinology has created all the necessary conditions for comfortable and peaceful treatment and rest away from the noise and fuss of the big city. The center is beautifully located near a modern green park equipped with walking areas, play grounds for children and sport grounds, on a noise-proof protected area with an individual entrance to the park. The center will please its guests and the guests of the city with excellent transport accessibility. Metro station «Academicheskaya», bus and tram stops are all within walking distance. The Moscow Kremlin, Zaryadje Park, the Great Moscow State Circus, the building of the Moscow State University that has long become one of the city’s symbols, and many more sightseeing spots are available for you within 30-minute travel time. If desired, you can enter the territory by service and personal vehicles and place them at a guarded parking lot.

Directorate of the Center

Ivan Dedov
CEO of Endocrinology Center, Presidium Member of the Russian Academy of Sciences, Full Professor, holder of Habilitation degree in Medicine, President of the Russian Endocrinologist Association, chief non-staff endocrinology expert for Russia’s Ministry of Health

 

 

Natalia Mocrysheva
Acting Director of the Center, Deputy Director of the Center for Scientific and Therapeutic Work, Chief Physician. Corresponding member of RAS, Doctor of Medical Sciences, physician of the highest qualification grade

 

 

Galina Melnichenko
Deputy Director of the Center, Head of Endocrinology Institute, RAS Academician, Full Professor, holder of Habilitation degree in Medicine

 

 

Marina Shestakova
Deputy Director of the Center - Director of the Diabetes Institute,
RAS Academician, Professor, Doctor of Medical Sciences

 

 

Valentina Peterkova
Chief Scientific Officer of the Institute for Pediatric Endocrinology,
RAS Academician, Professor, Doctor of Medical Sciences, chief non-staff pediatric endocrinology specialist for Russia’s Ministry of Health

 

 

Olga Bezlepkina
Acting Deputy Director of the Center - Director of the Institute for Pediatric Endocrinology.
Doctor of Medical Sciences, Professor, physician of the highest qualification grade

 

 

Elena Andreeva
Deputy Director of the Center - Director of the Institute for Reproductive Medicine
Head of Endocrine Gynecology Department. Professor, Doctor of Medical Sciences, physician of the highest qualification grade

 

 

Pavel Rumyantsev
Acting Deputy Director of the Center - Director of the Institute for Oncoendocrinology. Head of the Department of Radionuclide Diagnostics and Therapy
Doctor of Medical Sciences, physician of the highest qualification grade

 

 

Anatoly Tulpakov
Deputy Director of the Center - Director of the Institute for Personalized Medicine
Head of the Department of Hereditary Childhood Endocrinopathies. Doctor of Medical Sciences

 

 

Catherine Pigarova
Acting Director of the Institute for Higher Education and Additional Professional Training
Candidate of Medical Sciences, leading researcher, physician of the highest qualification grade

 

 

Catherine Troshina
Deputy Director, Endocrinology Services Coordination Center. Head of the Coordinating Council of the National Medical Research Center for Endocrinology. Head of Therapeutic Endocrinology
RAS Corresponding Member, Professor, Doctor of Medical Sciences, physicianof the highest qualification grade

 

Natalia Volvodz
Deputy Director of the Center for Scientific, Advisory and Diagnostic Work. Head of the Advisory and Diagnostic Center
Doctor of Medical Sciences, Professor, physician of the highest qualification grade

 

 

Larisa Dzeranova
Academic Secretary
Doctor of Medical Sciences, Chief Scientist

 

 

Mikhail Sokolenko
Deputy Director of the Center for General Affairs

 

 

Irina Belovalov
Assistant to the President of the Center
Candidate of Medical Sciences

 

 

Maria Shatohina
Head Hurse of the Center
Nurse of the highest qualification grade

 

 

Institute of Clinical Endocrinology

The Institute for Clinical Endocrinology was founded in 1990 and since its establishment until 2001 was headed by Eugenia Marova, an Honored Doctor of the Russian Federation, recipient of the USSR State Prize, Doctor of Medical Sciences, Professor.

The Institute has accumulated unique experience in treating patients with rare (including orphan) endocrine diseases using the latest genetic, immunological and hormonal metabolic studies, modern ultrasonic and radiographic (densitometry, multislice computed tomography) methods and magnetic resonance imaging. Complex X-ray endovascular surgeries are carried out in the center allowing to localize hormonally active pituitary and adrenal glands tumors.

All departments of the Institute work according to the principles of multidisciplinary approach and continuity in diagnostics and treatment of each particular patient. If a life-long supervision is needed patients from the Institute for Pediatric Endocrinology are transferred to other departments of the National Medical Research Center for Endocrinology. Patient management is carried out in accordance with up-to-date international protocols to achieve best results.

The Institute for Clinical Endocrinology is a unique complex that unites endocrinologists, surgeons, X-ray diagnostics and laboratory testing services, promptly performing diagnostics, conservative and surgical treatment, preventive treatment and rehabilitation in diseases of the hypothalamic–pituitary axis, adrenal glands, thyroid and parathyroid glands. Genetic, hormonal and metabolic disorders in endocrinopathies, including of autoimmune nature, are being detected.

The Institute has established and is actively implementing a medically and socially effective form of education and treatment in Obesity and Osteoporosis Schools.

Doctors of the Center’s three subdivisions cooperate in the Department of Reproductive Endocrinology: gynecological endocrinologists, andrologist urologists and reproductive gynecologists. The department offers a wide range of services to provide highly qualified medical care (conservative and surgical treatment) to women and men suffering from various endocrine diseases resulting in reproductive problems, including assisted reproductive technologies (ART) allowing to treat not only a spouse, but also the couple.

Training programs on breast diseases, pregnancy planning and management, birth control, and menopausal specifics in women with endocrine pathology have been developed and are carried out monthly for practical healthcare professionals..

Structure of Institute for Clinical Endocrinology:
• Department of Neuroendocrinology and Osteopathies
• Department of Parathyroid Glands Pathology 
• Department of Therapeutic Endocrinology
• Department of Surgery

Diabetes Institute

Diabetes mellitus today is a major hazard for humanity. A rapid increase in morbidity, early incapacitation and high mortality rates account for the medical and social significance of the disease. Therefore, diabetes is a top priority for health professionals around the world. The United Nations passed a resolution on diabetes in 2006. It was the fourth resolution to be adopted for particularly dangerous infections, as malaria, tuberculosis and HIV. However, long before that, on November 14, 1989, by Order No. 231 of the Director of the All-Union Endocrinology Scientific Center of the USSR Academy of Medical Sciences Professor Ivan Dedov, the Institute for Diabetes was created to improve the early diagnostics, prevention and treatment of diabetes mellitus in the Soviet Union

At present the Institute for Diabetes is the base center in the Russian Federation to provide specialized and high-tech assistance to diabetes patients from the debut of the disease up to the terminal stages of vascular complications, as well as the reference center of the Ministry of Health and Social Development of the Russian Federation for development, testing and introduction of innovative technologies in diagnostics, prevention and treatment of diabetes mellitus and its complications.

Advantages of treatment at the Institute for Diabetes at the National Medical Research Center for Endocrinology:

Integrity principle of examination and treatment: all the necessary medical care is provided at one institution.

Having visited the Diabetes Institute, the patient receives comprehensive assistance of all specialists in diabetology and related specialties - cardiology, nephrology, ophthalmology, gynecology, vascular surgery (stenting, angioplasty) and functional diagnostic methods. We are not treating a disease, we’re treating the patient.

Principle of ultimate organ protection.

World-class technologies have been introduced to prevent the development of vascular complications in diabetes (blindness, kidney failure, myocardial infarction, stroke, gangrene and lower limb amputation). The task for the specialists is to offer the most effective methods of treatment with minimal traumatization - preservation and restoration of vision, prevention of limb amputations, maintenance of kidney function, restoration of blood flow in damaged vessels.

Principle of continuous observation.

Patients can be observed lifelong obtaining up-to-date specialized medical care as both in- and out-patients.

The Institute for Diabetes is engaged in research in three main directions:

  • Genome and post-genome technologies and nanotechnologies in the study of the development mechanisms of diabetes mellitus and its complications.
  • Molecular genetic and hormonal metabolic aspects of diagnostics, prevention, treatment and rehabilitation of patients with systemic vascular complications of diabetes mellitus.
  • Prevention of diabetes mellitus, metabolic syndrome and obesity as socially significant diseases.

Structure of the Institute for Diabetes:
• Diabetic Kidney Disease and Post-Transplant Rehabilitation Department
• Diabetic Retinopathy and Ophthalmic Surgery Department
• Diabetic Foot Department
• Department of Cardiology and Vascular Surgery
• Department of Epidemiology and the State Register of Diabetes Mellitus
• Diabetes Prediction and Innovation Department
• Diabetes and Pregnancy Center
• Insulin Pump Therapy Center

Institute of Pediatric Endocrinology

The clinic of the Institute for Pediatric Endocrinology turned 50 in 2011. It is the first specialized clinic in Russia for diagnostics and treatment of endocrine diseases in children. At present, the most recent technologies using genomic markers and innovative methods of treatment based on the latest pharmacological achievements are being developed and introduced into clinical practice, methodological basics of prediction and prevention of endocrinopathies in children are being refined.

Key priorities of the Institute:

  • Optimum physical and sexual development of children and adolescents in various endocrine diseases
  • Creating National Registers of Endocrine Diseases
  • Developing and implementing screening programs for early detection of endocrine diseases
  • Developing and implementing preventive programs aimed at reducing morbidity and improving life quality of children with endocrine diseases
  • Developing methods of psychosocial adaptation of patients with different endocrine pathologies
  • Genetic family counseling in families of patients with various endocrine diseases

Admissions Office:

6 to 7 thousand children and adolescents are examined and treated yearly at the Institute for Pediatric Endocrinology by means of the high-tech and specialized endocrinological care. 90% of them come from regions of the Russian Federation, 10% are from Moscow and non-CIS countries.

Medical care is provided at an in-patient facility and the diagnostics and advisory center.

Research and methodological activity of the Institute:

The staff of the Institute consists of leading specialists in Russia - professors, doctors and candidates of medical sciences who have great experience and proficiency in latest technologies of diagnostics and treatment of endocrine diseases in children and adolescents. They work in close contact with pediatric endocrinologists from all regions of Russia, many of whom are co-authors of scientific researches, national registers and multi-center programs. The Institute for Pediatric Endocrinology also collaborates with leading foreign clinics and scientific centers. A number of educational activities are held as a part of post-graduate education and advanced training programs. Doctors undergo primary specialization and retraining in pediatric endocrinology. The Institute organizes the All-Russian and Regional Conferences on Pediatric Endocrinology. The Institute’s specialists carry out advisory assistance in the regions of the Russian Federation, give guest lectures and seminars for regional pediatric endocrinologists, publish articles in leading domestic and foreign journals, methodological guidelines, monographs.

The Alfa-Endo Program for Children with Endocrine Diseases contributes to improving the quality and accessibility of health care for children. The program is financed by Alpha-Group, implemented by the Foundation for Support and Development of Philanthropy "CAF" together with the National Medical Research Center for Endocrinology and the Charity Foundation "Life Line". 

The program’s main fields of work:

  • Molecular genetic diagnostics of childhood endocrinopathies
  • Educational programs for specialists
  • Introducing modern computer technologies in diabetology
  • Supporting patient communities
  • Preventing obesity in children

The curator of the program from the National Medical Research Center for Endocrinology is Valentina Peterkova, Director of the Institute for Pediatric Endocrinology, Deputy Director for Scientific Work, Chief Specialist - Pediatric Endocrinologist of the Ministry of Health of Russia, RAS Corresponding Member, Professor, Doctor of Medical Sciences.

The program’s webpage - http://alfa-endo.ru/

Structure of Institute for Pediatric Endocrinology:
• Pediatric Diabetes Department
• Department of Pediatric Thyroidology, Reproductive and Somatic Development
• Pediatric Endocrine Tumors Department
• Pediatric Surgery Department
• Insulin Pump Therapy and Remote Monitoring Center

Institute of Oncoendocrinology

The Institute for Oncoendocrinology is a multidisciplinary team, a community of specialists, ideas and technologies. It is radiomics, oncogenomics, radioguided surgery, biodosimetry, theranostics and other innovative directions of science and clinical practice.

The most significant advances in modern medicine come up at an intersection of sciences, such as molecular genetics and therapy, molecular imaging and surgery, dosimetry and radionuclide therapy. Achieving practical results in this area requires proactive multidisciplinary interaction of experts - holders of ideas, competences and experience. Hybridization of technologies in radiology, for example, creates favorable ground for interdisciplinary communication of radiologists, endocrinologists, oncologists and other doctors. However, without radiochemical and medical physicists professional symbiosis will not be complete and, as a result, successful. On the other hand, if a surgeon or therapist does not aim for a contact in a molecular genetic and pathomorphological laboratory, they will miss out on finding like-minded professionals in lab workers and pathologists, respectively.

The Institute for Oncoendocrinology was founded in 2018 as part of the National Medical Research Center for Endocrinology in order to consolidate specialists of various profiles to improve prevention, diagnostics, treatment and rehabilitation of patients with endocrine and endocrine-dependent tumors.

At the moment the Institute of Oncoendocrinology is comprised of:
• Radionuclide Diagnostics Department
• Radionuclide Therapy Department
• Phoniatric Rehabilitation Office

In the future it is planned to create the following structural subdivisions:
• Intraoperative radio-guidance group
• Clinical dosimetry and theranostics group
• Laboratory of oncomorphology
• Laboratory of molecular oncoendocrinology
• Onco-biobank Laboratory
• Radiation Safety Service

Institute of Reproductive Medicine

Reproductive health is an area of medicine that traditionally is the focus field of endocrinologists, obstetrician gynecologists, pediatricians, neonatologists, urologists and andrologists, and that begins to attract the attention of doctors of other specialties. Declining fertility and ultimately infertility is a common problem: 1 in 7 married couples is infertile. The decline in fertility in economically developed countries leads to the population ageing and increases the financial burden on healthcare expenditures.

The problem of barren marriage goes far beyond different fertility recovery technologies. A significant part of the reasons for the decline in fertility is formed in the prenatal and early childhood periods and is potentially eliminated with timely preventive measures. Endocrine infertility inevitably entails a powerful plume of metabolic disorders resulting in severe chronic diseases of endocrine, cardiovascular, and other systems and organs. In the elder age group the focus of medical science has landed on menopause problems and a new issue - andropause. So the perennial topic of "men and women" has gained traction.

Time is flying rapidly, and humanity now has enormous and diverse information about the reproductive health of men and women. Predictably, the revolutionary changes that had taken place in recent decades have resulted from the increasing possibilities of diagnostic methods. Today reproductive medicine should take a step from simply accumulating facts towards introducing the concept of evidence-based medicine and actually reappraise the values.

The real problem of using the world scientific experience in our country is that the principles of evidence-based medicine, widely applied in clinical practice by therapists and surgeons, have not yet taken their place in reproductive medicine. Accordingly, the top priority of our activity will be to get acquainted with the world trends of reproductive science and to assess the acceptability of the new knowledge in terms of evidence-based medicine. Criteria of acceptability are effectiveness and safety of diagnostic methods, validity of treatment methods.

In general, we see our task as structuring the latest scientific data, introducing them into practice and making them as accessible as possible to a wide range of medical practioners. Involving various specialists (endocrinologists, obstetrician gynecologists, pediatricians, andrologists, geneticists, epidemiologists, cardiologists, therapists, etc.) will allow to successfully integrate their efforts in treatment of diseases associated with fertility reduction, and to determine the most effective strategy of prevention and treatment.

The Institute for Reproductive Medicine will help to find a solution to any reproductive problem and at any age - from disorders of sexual development to diagnostics and treatment of infertility or treatment of climacteric disorders.

Continuity of medical care, timely prevention and correction of reproductive disorders will hopefully permit not only to solve problems, but also to effectively prevent them in the future.

Main activities of the Institute for Reproductive Medicine:
• Monitoring the development of the reproductive system in children and adolescents
• Treatment of gender pathology and sexual development in children and adolescents
• Pregnancy planning
• Regaining pregnancy in infertile couples (including IVF)
• Gynecological surgery
• Andrology and urological surgery
• Age deficiency of sex hormones: maintaining quality of life

Structure of Institute for Reproductive Medicine:
• Complex Diagnostics of Mammary Gland Diseases
• Andrology and Urology Department
• Assisted Reproductive Technology Department
• Endocrine Gynecology Department with a day patient facility
• Perinatology Department

Institute of Personalized Medicine

Personalized medicine is a rapidly evolving field of healthcare, based on an integrated, coordinated and individual approach to each patient to analyze the onset and course of the disease. Medicine has always sought personalization, but before the human genome was deciphered, it was more a dream than a reality.

In 2017 the Institute for Personalized Medicine was established as a part of the National Medical Research Center for Endocrinology, based on personalized prevention, risk prediction and targeted therapy.

The main approaches of personalized medicine include:

  • prediction of a disease probability based on genomic data;
  • transition from the traditional clinical to personalized diagnostics considering a patient’s individual characteristics;
  • selection of treatment strategy according to a patient’s individual indicators;
  • pharmacological aspects involving individual medication selection by combining genomic predictions and therapeutic drug monitoring.

Structure of the Institute for Personalized Medicine:

  • Genomic research laboratory: gene panel sequencing by NGS method, such as DM and Hyperinsulinism, Congenital Hypothyroidism, Rickets, Hypopituitarism, Hypogonadotropic Hypogonadism, Familial Lipodystrophies, Pituitary Adenomas, Adrenal Insufficiency, Fluid and Electrolyte Disorders, Disorders of Sex Development, Primary Hyperparathyroidism, Primordial dwarfism, Osteogenesis imperfecta; whole exomal sequencing; Sanger sequencing; Real-time PCR.
  • Metabolome research laboratory: studying a range of steroid hormones by high performance liquid chromatography with tandem mass spectrometry (HPLS-MS/MS); analysis of priority estrogens in serum.
  • Laboratory of Genetics of Monogenic Endocrine Diseases
  • Fundamental Pathomorphology Department: morphological (cytological, histological) and immune morphological diagnostics of endocrine diseases. Along with the routine diagnostics express morphological diagnostics can be carried out using material obtained during FNA and surgical interventions.
  • Laboratory of Cell Technologies: development of methods of diabetes mellitus therapy using technologies of reprogramming and genome editing; the study of molecular development mechanisms of multiple endocrine neoplasias; development of new approaches to gene therapy of inherited diseases.
  • Bioinformatics Division: processing of primary data obtained by methods of high-performance sequencing (NGS); molecular biological and clinical annotation of identified genetic variants; storing and recording the test results in our own database.
  • Biobank: Creating biobanks along with patient registers is considered the main way to carry out translational research introducing fundamental knowledge into practical medicine. Currently a biobank of blood plasma and DNA specimen is being created.
  • Hereditary Childhood Endocrinopathies Department.

Structure of Institute for Personalized Medicine:
• Hereditary Childhood Endocrinopathies Department
• Laboratory of Genetics of Monogenic Endocrine Diseases
• Metabolome Research Laboratory
• Cell Technologies Laboratory
• Fundamental Pathomorphology Department

Diagnostic Advisory Centre

The Diagnostic and Advisory Center of the National Medical Research Center for Endocrinology provides a full range of highly qualified advisory, diagnostic and therapeutic assistance to adults and children.

Patients are received by various specialists including candidates and doctors of medical sciences, physicians of the highest qualification grade.

DAC has the latest instrumental and technical equipment, including all types of ultrasound, laboratory, X-ray diagnostic devices.

DAC of the National Medical Research Center for Endocrinology is the only specialized endocrinological advisory and diagnostic center in the country allowing to promptly carry out diagnostics using expert class innovative equipment, to timely establish an accurate diagnosis and to prescribe necessary treatment in time, approaching each patient individually.

Unique features of the Diagnostic and Advisory Center:

  • Highly professional and qualified medical staff with extensive experience
  • Competence, responsibility, complete confidentiality, individual approach to each patient
  • A wide range of healthcare services
  • The best expert-level medical equipment from international manufacturers
  • Own laboratory that enables to carry out diagnostic procedures as soon as possible
  • Experience in the treatment of famous politicians, culture and science personalities.

Structure of the Diagnostic and Advisory Center:
• Gastroenterology, proctology, endoscopy
• X-ray Diagnostics Department: CT Department, MRI
• Otorhinolaryngology
• Psychotherapy, psychiatry

Inter-agency units

• Ultrasound Diagnostics Department
• Personalized Therapy of Endocrinopathies Departments
• Office of Renal pathology extracorporeal treatment methods 
• Day patient facility of general endocrinology
• Central Sterilization Unit
• Laboratory complex
• General Clinical Department
• Admission Office
• Rehabilitation Department
• Dental Department
• Medical cosmetology office
• Laboratory production complex